Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February-18 April 2020

被引:57
作者
Al Kuwari, Hanan M. [1 ]
Abdul Rahim, Hanan F. [2 ]
Abu-Raddad, Laith J. [3 ]
Abou-Samra, Abdul-Badi [4 ]
Al Kanaani, Zaina [5 ]
Al Khal, Abdullatif [4 ]
Al Kuwari, Einas [6 ]
Al Marri, Salih [1 ]
Al Masalmani, Muna [4 ]
Al Romaihi, Hamad E. [1 ]
Al Thani, Mohamed H. [1 ]
Coyle, Peter, V [6 ]
Latif, Ali N. [5 ]
Owen, Robert [7 ]
Bertollini, Roberto [1 ]
Butt, Adeel Ajwad [4 ,8 ,9 ]
机构
[1] Minist Publ Hlth, Off Minister Publ Hlth, Doha, Qatar
[2] Qatar Univ, Coll Hlth Sci, QU Hlth, Doha, Qatar
[3] Cornell Univ, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar
[4] Hamad Med Corp, Dept Med, Doha, Qatar
[5] Hamad Med Corp, Business Intelligence Unit, Doha, Qatar
[6] Hamad Med Corp, Dept Lab Med, Doha, Qatar
[7] Hamad Med Corp, Natl Ambulance Serv, Doha, Qatar
[8] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
[9] Weill Cornell Med Coll, Dept Med, Doha, Qatar
来源
BMJ OPEN | 2020年 / 10卷 / 10期
关键词
public health; epidemiology;
D O I
10.1136/bmjopen-2020-040428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To define the epidemiological curve of COVID-19 in Qatar and determine factors associated with severe or critical illness. Design Case series of first 5685 COVID-19 cases in Qatar. Setting and participants All confirmed COVID-19 cases in the State of Qatar between 28 February and 18 April 2020. Main outcome measures Number of total and daily new COVID-19 infections; demographic characteristics and comorbidity burden and severity of infection; factors associated with severe or critical illness. Results Between 28 February and 18 April 2020, 5685 cases of COVID-19 were identified. Median age was 34 (IQR 28-43) years, 88.9% were male and 8.7% were Qatari nationals. Overall, 83.6% had no concomitant comorbidity, and 3.0% had three or more comorbidities. The overwhelming majority (90.9%) were asymptomatic or with minimal symptoms, with 2.0% having severe or critical illness. Seven deaths were observed during the time interval studied. Presence of hypertension or diabetes was associated with a higher risk of severe or critical illness, but age was not. The epidemiological curve indicated two distinct patterns of infection, a larger cluster among expatriate craft and manual workers and a smaller one among Qatari nationals returning from abroad during the epidemic. Conclusion COVID-19 infections in Qatar started in two distinct clusters, but then became more widespread in the population through community transmission. Infections were mostly asymptomatic or with minimal symptoms and associated with very low mortality. Severe/critical illness was associated with presence of hypertension or diabetes but not with increasing age.
引用
收藏
页数:8
相关论文
共 18 条
  • [1] Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
    不详
    [J]. PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2020, 16 (01): : 9 - 26
  • [2] CDC, 2020, CONT TRAC COVID 19
  • [3] Qatar experience on One Health approach for middle-east respiratory syndrome coronavirus, 2012-2017: A viewpoint
    Farag, Elmoubasher
    Nour, Mohamed
    Islam, Md Mazharul
    Mustafa, Aya
    Khalid, Minahil
    Sikkema, Reina S.
    Alhajri, Forhud
    Bu-Sayaa, Abdulla
    Harourib, Mohamed
    Van Kerkhove, Maria D.
    Elkholy, Amgad
    Malik, Sk Mamunur R.
    Reusken, Chantal
    Koopmans, Marion
    AlHajri, Mohd M.
    [J]. ONE HEALTH, 2019, 7
  • [4] Google, 2020, COVID 19 COMM MOB RE
  • [5] First Case of 2019 Novel Coronavirus in the United States
    Holshue, Michelle L.
    DeBolt, Chas
    Lindquist, Scott
    Lofy, Kathy H.
    Wiesman, John
    Bruce, Hollianne
    Spitters, Christopher
    Ericson, Keith
    Wilkerson, Sara
    Tural, Ahmet
    Diaz, George
    Cohn, Amanda
    Fox, LeAnne
    Patel, Anita
    Gerber, Susan I.
    Kim, Lindsay
    Tong, Suxiang
    Lu, Xiaoyan
    Lindstrom, Steve
    Pallansch, Mark A.
    Weldon, William C.
    Biggs, Holly M.
    Uyeki, Timothy M.
    Pillai, Satish K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10) : 929 - 936
  • [6] Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, 10.1016/S0140-6736(20)30211-7]
  • [7] Clinical and virological data of the first cases of COVID-19 in Europe: a case series
    Lescure, Francois-Xavier
    Bouadma, Lila
    Duc Nguyen
    Parisey, Marion
    Wicky, Paul-Henri
    Behillil, Sylvie
    Gaymard, Alexandre
    Bouscambert-Duchamp, Maude
    Donati, Flora
    Le Hingrat, Quentin
    Enouf, Vincent
    Houhou-Fidouh, Nadhira
    Valette, Martine
    Mailles, Alexandra
    Lucet, Jean-Christophe
    Mentre, France
    Duval, Xavier
    Descamps, Diane
    Malvy, Denis
    Timsit, Jean-Francois
    Lina, Bruno
    Van-der-Werf, Sylvie
    Yazdanpanah, Yazdan
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (06) : 697 - 706
  • [8] Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
    Lu, Roujian
    Zhao, Xiang
    Li, Juan
    Niu, Peihua
    Yang, Bo
    Wu, Honglong
    Wang, Wenling
    Song, Hao
    Huang, Baoying
    Zhu, Na
    Bi, Yuhai
    Ma, Xuejun
    Zhan, Faxian
    Wang, Liang
    Hu, Tao
    Zhou, Hong
    Hu, Zhenhong
    Zhou, Weimin
    Zhao, Li
    Chen, Jing
    Meng, Yao
    Wang, Ji
    Lin, Yang
    Yuan, Jianying
    Xie, Zhihao
    Ma, Jinmin
    Liu, William J.
    Wang, Dayan
    Xu, Wenbo
    Holmes, Edward C.
    Gao, George F.
    Wu, Guizhen
    Chen, Weijun
    Shi, Weifeng
    Tan, Wenjie
    [J]. LANCET, 2020, 395 (10224) : 565 - 574
  • [9] How Do the First Days Count? A Case Study of Qatar Experience in Emergency Risk Communication during the MERS-CoV Outbreak
    Nour, Mohamed
    Alhajri, Mohd
    Farag, Elmoubasher A. B. A.
    Al-Romaihi, Hamad E.
    Al-Thani, Mohamed
    Al-Marri, Salih
    Savoia, Elena
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2017, 14 (12):
  • [10] Omrani AS, 2020, BMC INFECT DIS, DOI DOI 10.1186/S12879-020-05511-8